Start Date
February 15, 2017
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
XAPPORT
A mobile device app based on different guidelines provides adequate guidance to physicians attending patients undergoing elective surgery, who have to interrupt treatment with rivaroxaban for surgery, in deciding how to approach the pre- and postoperative management of anticoagulation.
"Expert Panel (gold standard)"
A national panel of experts comprising anesthetists and surgeons from various disciplines advised in developing an algorithm supporting physicians how to approach the perioperative management of anticoagulation in patients receiving rivaroxaban and requiring elective surgery.
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Bayer
INDUSTRY